First American Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
10,959
-50
-0.5% -$9.4K 0.12% 109
2026
Q1
$2.17M Buy
11,009
+618
+6% +$119K 0.14% 104
2025
Q4
$1.91M Sell
10,391
-11
-0.1% -$1.93K 0.12% 106
2025
Q3
$1.6M Sell
10,402
-75
-0.7% -$11.4K 0.1% 110
2025
Q2
$1.46M Sell
10,477
-1,816
-15% -$255K 0.1% 109
2025
Q1
$1.81M Buy
12,293
+2,136
+21% +$309K 0.13% 104
2024
Q4
$1.33M Buy
10,157
+545
+6% +$76.3K 0.09% 113
2024
Q3
$1.5M Sell
9,612
-1,170
-11% -$189K 0.11% 107
2024
Q2
$1.68M Buy
10,782
+1,324
+14% +$199K 0.13% 99
2024
Q1
$1.28M Buy
9,458
+3,048
+48% +$404K 0.1% 115
2023
Q4
$863K Sell
6,410
-23,684
-79% -$3.08M 0.07% 127
2023
Q3
$4.08M Buy
30,094
+264
+0.9% +$36.1K 0.37% 66
2023
Q2
$4.27M Sell
29,830
-137
-0.5% -$20.2K 0.37% 66
2023
Q1
$4.16M Sell
29,967
-3,892
-11% -$524K 0.38% 65
2022
Q4
$4.59M Sell
33,859
-4,340
-11% -$544K 0.44% 58
2022
Q3
$4.19M Sell
38,199
-3,936
-9% -$499K 0.44% 60
2022
Q2
$5.57M Buy
42,135
+5,576
+15% +$732K 0.57% 51
2022
Q1
$4.85M Buy
+36,559
New +$4.38M 0.41% 60

Other funds holding AZN

First American Bank's AZN Position: Q2 2026 in Review

First American Bank reduced its AstraZeneca (AZN) stake by 0.45% in Q2 2026, selling an estimated $9.4K and leaving 10,959 shares worth $2.08M. The position accounts for 0.12% of the portfolio, ranked #109.

First American Bank first reported a position in AZN in Q1 2022 and has held it in 18 quarters since. The position peaked at $5.57M in Q2 2022. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • First American Bank held 10,959 shares of AstraZeneca worth $2.08M as of Q2 2026.
  • First American Bank sold 50 AstraZeneca shares in Q2 2026, an estimated $9.4K.
  • AstraZeneca made up 0.12% of First American Bank's portfolio in Q2 2026, its #109 holding.
  • First American Bank first reported a position in AstraZeneca in Q1 2022 and has held it in 18 quarters since.
  • First American Bank's AstraZeneca position peaked at $5.57M in Q2 2022.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First American Bank's 13F filing for Q2 2026, filed 15 Jul 2026.